CONCEPT: Crossover Efficacy Pain Trial in Motor Cortex Stimulation for Intractable Neuropathic Pain
Pain, Intractable, Facial Pain
About this trial
This is an interventional treatment trial for Pain, Intractable focused on measuring Motor Cortex Stimulation, Pain treatment, Central post-stroke pain (CPSP), Trigeminal neuropathic pain (TGN), Facial pain, Neurostimuation, Cortical lead, Neuropathic pain
Eligibility Criteria
Inclusion Criteria: CPSP or TGN/facial pain refractory to other medical treatments Pain > 1 year prior to baseline Pain intensity with an average daily VAS score > 5 demonstrated by 12 ratings across 4 days Stable pain medication for > 1 month prior to baseline Exclusion Criteria: CPSP with important paresis/severe motor deficit in the area of pain TGN/facial pain with complete deafferentation pain Atypical facial pain, i.e. when objective evidence for neuropathic facial pain syndromes is lacking and when specific psychological and behavioral factors can be identified Pain associated with malignant neoplastic disease anywhere in the body or head History of epilepsy Presence of a deterioration of cognitive functions
Sites / Locations
- Universitätsklinik Innsbruck, Universitätsklinik für Neurochirurgie
- Hopital Erasme, Service de Neurochirurgie
- UCL St luc, Neurochirurgie
- AZ St Lucas, Neurochirugie
- UZ Gasthuisberg , Department of Neurosurgery
- CH de la Citadelle
- Maria Middelares ZH
- Universitätsklinikum Schleswig-Holstein, Campus Lübeck
- Klinikum der Philipps-Universität Marburg
- Santa Creu I Sant Pau, Servicio de Neurocirugia
- Hospital Gregorio Maranon, Servicio de Neurologia